Clinical Trial Update: Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and efficacy of the SpectraCure P18 System for recurrent prostate cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• SpectraCure P18 System

Snippet

Sponsor: SpectraCure AB | Conditions: Recurrent Prostate Cancer | Phase 1, Phase 2 | Status: RECRUITING